Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R
Dominique S. Meyer(Idorsia (Switzerland)), Mohamed Bentires‐Alj(University of Basel)
Cited by 65
Related Papers
Activating Mutations of the Noonan Syndrome-Associated <b> <i>SHP2/PTPN11</i> </b> Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
|Cancer Research|2004|512
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling
|Proceedings of the National Academy of Sciences|2013|321
Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase
|Cell|2011|276
Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition
|Science Signaling|2019|229
Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition
|Breast Cancer Research|2016|125